Annals of Oncology

Obituary:

D. K. Hossfeld and A. T. van Oostreom

Prof. Dr. E. van der Schueren
Ann Oncol 9: 343.
[PDF] [Request Permissions]

News:

Will the nomination of Dr. Brundtland help cancer care in the world?
Ann Oncol 9: 345.
[PDF] [Request Permissions]

European center for special radiotherapy
Ann Oncol 9: 345-346.
[PDF] [Request Permissions]

Xenotransplants: Moratorium or not?
Ann Oncol 9: 346.
[PDF] [Request Permissions]

Germany and Switzerland lukewarm on anti-smoking
Ann Oncol 9: 347.
[PDF] [Request Permissions]

Drug addiction: Change of attitude in the US?
Ann Oncol 9: 347.
[PDF] [Request Permissions]

Awards, appoinments
Ann Oncol 9: 347-348.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 348-349.
[PDF] [Request Permissions]

Book reviews:

E. Cervera

Book review
Ann Oncol 9: 350.
[PDF] [Request Permissions]

R. Iggo

Book review
Ann Oncol 9: 462.
[PDF] [Request Permissions]

Editorial:

J. M. Goldman

Cost-effectiveness of interferon- for chronic myeloid leukemia
Ann Oncol 9: 351-352.
[PDF] [Request Permissions]

A. R. Timothy and G. J. R. Cook

PET scanning in clinical oncology
Ann Oncol 9: 353-355.
[PDF] [Request Permissions]

Special articles:

R. E. Parchment, M. Gordon, C. K. Grieshaber, C. Sessa, D. Volpe, and M. Ghielmini

Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests
Ann Oncol 9: 357-364.
[Abstract] [PDF] [Request Permissions]

Review:

R. Grilli, S. Minozzi, A. Tinazzi, R. Labianca, T. A. Sheldon, and A. Liberati

Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients
Ann Oncol 9: 365-374.
[Abstract] [PDF] [Request Permissions]

Introduction:

C. J. H. Williams and J. Deeks

Reviews on evidence-based cancer medicine
Ann Oncol 9: 375.
[PDF] [Request Permissions]

Review on evidence-based cancer medicine:

D. L. Hunt, R. B. Haynes, and G. P. Browman

Searching the medical literature for the best evidence to solve clinical questions
Ann Oncol 9: 377-383.
[PDF] [Request Permissions]

Rapid publication:

F. L. Clark, M. W. Drummond, S. Chambers, B. A. Chapman, and W. N. Patton

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin’s lymphoma
Ann Oncol 9: 385-387.
[Abstract] [PDF] [Request Permissions]

Original articles:

A. Messori

Cost-effectiveness of interferon in chronic myeloid leukaemia: Analysis of four clinical studies
Ann Oncol 9: 389-396.
[Abstract] [PDF] [Request Permissions]

R. Hustinx, P. Paulus, N. Jacquet, G. Jerusalem, T. Bury, and P. Rigo

Clinical evaluation of whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases
Ann Oncol 9: 397-401.
[Abstract] [PDF] [Request Permissions]

J. Bergh, T. Wiklund, B. Erikstein, T. Fornander, N.-O. Bengtsson, P. Malmström, P. Kellokumpu-Lehtinen, G. Anker, H. Bennmarker, and N. Wilking Scandinavian Breast Group, study SBG 9401

Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients
Ann Oncol 9: 403-411.
[Abstract] [PDF] [Request Permissions]

E.A. Diaz-Canton, V. Valero, Z. Rahman, E. Rodriguez-Monge, D. Frye, T. Smith, A.U. Buzdar, and G.N. Hortobagyi

Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy: The University of Texas M.D. Anderson Cancer Center experience and review of the literature
Ann Oncol 9: 413-418.
[Abstract] [PDF] [Request Permissions]

G. Vijuk and A.S. Coates

Survival of patients with visceral metastatic melanoma from an occult primary lesion: A retrospective matched cohort study
Ann Oncol 9: 419-422.
[Abstract] [PDF] [Request Permissions]

P. Perego, S. Romanelli, N. Carenini, I. Magnani, R. Leone, A. Bonetti, A. Paolicchi, and F. Zunino

Ovarian cancer cisplatin-resistant cell lines: Multiple changes including collateral sensitivity to Taxol
Ann Oncol 9: 423-430.
[Abstract] [PDF] [Request Permissions]

G. González, T. Crombet, M. Catalá, V. Mirabal, J. C. Hernández, Y. González, P. Marinello, G. Guillén, and A. Lage

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
Ann Oncol 9: 431-435.
[Abstract] [PDF] [Request Permissions]

A. M. Westermann, E. Havik, F. R. Postma, J. H. Beijnen, O. Dalesio, W. H. Moolenaar, and S. Rodenhuis

Malignant effusions contain lysophosphatidic acid (LPA)-like activity
Ann Oncol 9: 437-442.
[Abstract] [PDF] [Request Permissions]

G. Cavaletti, D. Fabbrica, C. Minoia, L. Frattola, and G. Tredici

Carboplatin toxic effects on the peripheral nervous system of the rat
Ann Oncol 9: 443-448.
[Abstract] [PDF] [Request Permissions]

Clinical Case:

H. J. Milionis and M. S. Elisaf

Psoriasiforum lesions as paraneoplastic manifestation in Hodgkin's disease
Ann Oncol 9: 449-452.
[PDF] [Request Permissions]

Short report:

L. Bozec, P. Bierling, P. Fromont, F. Lévi, P. Debat, E. Cvitkovic, and J. L. Misset

Irinotecan-induced immune thrombocytopenia
Ann Oncol 9: 453-455.
[Abstract] [PDF] [Request Permissions]

D. Castellano, P. Lianes, L. Paz-Ares, M. Hidalgo, J. A. Guerra, C. Gómez-Martin, H. Gómez, J. Calzas, and H. Cortés-Funes

A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer
Ann Oncol 9: 457-459.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

M. Venturini and L. Del Mastro

More on dose-intensity of anthracyclines in breast cancer
Ann Oncol 9: 461.
[PDF] [Request Permissions]

M. Piccart

This letter was reffered to the author, who responds as follows:
Ann Oncol 9: 461.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.